Ingredion ((INGR)) has held its Q1 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ingredion’s latest earnings call struck a cautious tone as strategic gains in higher-value ingredients ran headlong into operational setbacks and margin pressure. Management highlighted solid momentum in Texture and Healthful Solutions and strong demand for healthful ingredients like pea protein, yet investors were reminded that Argo refinery disruptions and currency headwinds sharply dented first-quarter profitability and forced a downgrade to full-year guidance.
Stable Top Line Masks Modest Revenue Slippage
Ingredion reported first-quarter 2026 net sales of $1.8 billion, a 1% decline from the prior year that underscored both resilience and strain. While the company managed to hold the line on revenue despite operational headwinds, softer demand in key U.S. and Canadian markets and mix pressure in Latin America hinted at a tougher underlying environment.
Texture & Healthful Solutions Extend Growth Streak
Texture & Healthful Solutions, a strategic focus area, notched its eighth consecutive quarter of volume gains with volumes up 2%, net sales up 2%, and operating income up about 1%. Management credited rising adoption of solutions-led offerings, strong clean-label demand, and favorable input costs and currency tailwinds in select regions for supporting this performance.
Solutions Portfolio Gains Scale and Strategic Importance
Ingredion’s solutions portfolio continued to outgrow the broader segment and now represents roughly $1 billion of revenue, or about 40% of segment sales. The company emphasized solutions-led selling and highlighted the use of AI-enabled formulation tools, which are shortening the time from customer brief to finished solution and deepening relationships with branded and private-label customers.
Healthful Ingredients Deliver Strong Volume Growth
Healthful ingredients were a bright spot as pea protein isolate sales surged more than 50% in the quarter and stevia-based solutions grew around 6%. Management pointed to broad-based demand for protein fortification and sugar reduction across food and beverage categories, suggesting that Ingredion’s portfolio is well aligned with long-term nutrition and wellness trends.
Argo Refinery Recovery Efforts Gain Traction
Following a significant operational incident at its Argo refinery, Ingredion assembled a multidisciplinary team to stabilize the facility and restore production. The company reported that downstream refinery output returned to normal levels by quarter-end and expressed confidence that the corn germ processing unit would be back online in the second quarter, with the event’s impact excluded from adjusted figures.
Balance Sheet Supports Investment and Returns
Despite near-term pressure, Ingredion underscored its balance sheet strength and ongoing capital deployment discipline, noting $33 million in year-to-date cash from operations after a planned $205 million working capital build. The company invested $110 million in capital expenditures in the first quarter while still returning cash to shareholders through $52 million in dividends and $14 million in share repurchases.
Disciplined M&A and Innovation-Focused Spending
Management reiterated a disciplined approach to mergers and acquisitions, targeting assets that enhance Texture and Healthful Solutions capabilities rather than broad-based expansion. The company also stressed that innovation spending, including AI-enabled R&D and solutions development, remains ring-fenced and protected, signaling a commitment to long-term growth even as near-term earnings are pressured.
Operating Income Suffers Double-Digit Decline
Adjusted operating income fell 22% year over year, with reported and adjusted operating income coming in at $203 million and $212 million respectively. This steep drop highlighted meaningful margin pressure across the portfolio, as operational issues, cost inflation, and currency impacts combined to erode profitability despite stable revenues.
Argo Operational Issues Deal a $40 Million Blow
The Argo facility proved a major drag on first-quarter results, with operational issues generating an estimated $40 million impact through higher maintenance, rework, and logistics costs. This was far worse than the previously expected $10 million to $15 million hit and was a key driver of weaker performance in the Food & Industrial Ingredients U.S./Canada segment.
U.S. and Canada Food & Industrial Segment Weakens
Food & Industrial Ingredients U.S./Canada net sales fell roughly 9% as volumes dropped about 7%, culminating in operating income of just $34 million. Beyond the Argo problems, the segment faced softer demand in certain food and industrial markets, underscoring a challenging operating backdrop in Ingredion’s home region.
Gross Profit and Margins Compress Sharply
Gross profit declined 14% in the quarter and gross margin slid to 22.4%, reflecting the combination of Argo-related disruptions, lower volumes, and a less favorable mix in U.S./Canada and Latin America. Transactional foreign exchange in Mexico further chipped away at margins, amplifying the impact of operational issues and emphasizing the company’s sensitivity to regional demand and currency moves.
Latin America Hit by FX and Softer Volumes
In Latin America, Food & Industrial Ingredients net sales edged up 1%, yet operating income fell around 9% to $115 million with margins near 20%, pressured by a stronger Mexican peso that created transactional FX headwinds. Softer volumes in Mexico and the Andean region added to the drag, highlighting that even modest top-line growth could not prevent profit erosion in the region.
Earnings and Cash Flow Under Near-Term Pressure
Adjusted diluted EPS fell by $0.63 year over year, driven primarily by a $0.71 margin impact and a $0.14 volume impact, partially offset by positive FX and other income contributions. Year-to-date cash from operations was $33 million following the working capital build, limiting immediate free cash flow and underscoring the importance of operational normalization and margin recovery in coming quarters.
Inflation and Commodity Costs Weigh on Margins
Ingredion is also grappling with broader cost pressures, including higher energy, logistics, and packaging costs, along with a rapid rise in tapioca prices in Asia-Pacific. Management noted that price pass-through on tapioca will likely lag cost inflation by roughly one to one and a half quarters and suggested that while within-year price increases are expected, they could carry indirect demand risks.
Guidance Downgraded as Outlook Reflects Argo and FX
Looking ahead, Ingredion lowered its full-year 2026 outlook, now expecting net sales to be flat to up low single digits and adjusted operating income to be down high single digits. The company guided to adjusted diluted EPS of $10.45 to $11.15, financing costs of $35 million to $45 million, a 26% to 27.5% effective tax rate, cash from operations of $725 million to $825 million, and capital expenditures of $400 million to $440 million, with segment forecasts assuming a gradual Argo recovery and ongoing FX and energy headwinds.
Ingredion’s earnings call painted a nuanced picture in which structural growth engines in Texture and Healthful Solutions, along with strong demand for healthful ingredients, coexist with acute operational and cost challenges. Investors will watch closely to see whether the company can execute on its recovery plan at Argo, restore margins, and convert its innovation investments into sustained earnings growth in the coming quarters.

